https://brainminds.jp/en/research/2105
Unleashing a New Era: Pioneering Therapies for α-Synucleinopathies – Brain/MINDS 2.0
This is the website of Brain/MINDS 2.0.
a new eraunleashingpioneeringtherapiessynucleinopathies
https://www.mdsabstracts.org/abstract/diagnosing-prodromal-synucleinopathies-what-is-the-role-of-cardiac-mibg-scintigraphy/
Diagnosing Prodromal Synucleinopathies – What is the Role of Cardiac MIBG Scintigraphy? - MDS...
Objective: We aimed to characterize cardiac MIBG uptake patterns in patients with an initial diagnosis of PAF (iPAF) and assess their role as a prognostic tool...
what isthe rolediagnosingprodromalsynucleinopathies
https://visualize.jove.com/33055242-lrrk2-mediates-microglial-neurotoxicity-via-nfatc2-in-rodent-models-of-synucleinopathies
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies | JoVE...
Oct 15, 2020 - LRRK2 drives synucleinopathy neuroinflammation via NFATc2 activation. Targeting LRRK2 may treat Parkinson's disease and related disorders.
mediatesmicroglialneurotoxicityviarodent
https://open.uni-marburg.de/entities/article/903ce447-7b7d-4b8b-8a09-ed38290f1af0
Saccade, pupil, and blink abnormalities in prodromal and manifest alpha-synucleinopathies
Neurodegenerative diseases like Parkinson's disease (PD) are on the rise. In the clinic, the phenotypic similarities between early stage PD and conditions such...
saccadepupilblinkabnormalitiesprodromal